Cargando…

Type I Interferonopathies in Children: An Overview

Notable advances in gene sequencing methods in recent years have permitted enormous progress in the phenotypic and genotypic characterization of autoinflammatory syndromes. Interferonopathies are a recent group of inherited autoinflammatory diseases, characterized by a dysregulation of the interfero...

Descripción completa

Detalles Bibliográficos
Autores principales:	d'Angelo, Debora M., Di Filippo, Paola, Breda, Luciana, Chiarelli, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044321/ https://www.ncbi.nlm.nih.gov/pubmed/33869112 http://dx.doi.org/10.3389/fped.2021.631329

Ejemplares similares

Type I Interferonopathies in Childhood
por: Haşlak, Fatih, et al.
Publicado: (2023)

The type I interferonopathies: 10 years on
por: Crow, Yanick J., et al.
Publicado: (2021)

Type I interferonopathies in pediatric rheumatology
por: Volpi, Stefano, et al.
Publicado: (2016)

Type I interferon–mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview
por: Rodero, Mathieu P., et al.
Publicado: (2016)

Growth and puberty in children with juvenile idiopathic arthritis
por: d’Angelo, Debora Mariarita, et al.
Publicado: (2021)

Interferonopathies masquerading as non-Mendelian autoimmune diseases: pattern recognition for early diagnosis
por: Gagne, Samuel, et al.
Publicado: (2023)

Bone Health in Children with Rheumatic Disorders: Focus on Molecular Mechanisms, Diagnosis, and Management
por: Di Marcello, Francesca, et al.
Publicado: (2022)

Covid-19–Associated Myopathy Caused by Type I Interferonopathy
por: Manzano, Giovanna S., et al.
Publicado: (2020)

Monogenic Autoinflammatory Diseases: State of the Art and Future Perspectives
por: Di Donato, Giulia, et al.
Publicado: (2021)

Case report: Increased troponin level in 125 children during COVID-19
por: Di Filippo, Paola, et al.
Publicado: (2023)

Total serum IgE levels as predictor of the acquisition of tolerance in children with food allergy: Findings from a pilot study
por: Dodi, Giulia, et al.
Publicado: (2022)

Clinical spectrum and currently available treatment of type I interferonopathy Aicardi–Goutières syndrome
por: Dell’Isola, Giovanni Battista, et al.
Publicado: (2023)

Myasthenia Gravis: An Acquired Interferonopathy?
por: Payet, Cloé A., et al.
Publicado: (2022)

Lung involvement in monogenic interferonopathies
por: Cazzato, Salvatore, et al.
Publicado: (2020)

Longitudinal prospective anthropometric evaluation in Caucasian prepubertal children with lactose intolerance
por: Lizzi, Mauro, et al.
Publicado: (2023)

Case Report: Mitral Valve Involvement and First-Degree Atrial-Ventricular Block in Two Patients With Multisystem Inflammatory Syndrome in Children
por: Di Filippo, Paola, et al.
Publicado: (2021)

Pulmonary Outcomes in Children Born Extremely and Very Preterm at 11 Years of Age
por: Di Filippo, Paola, et al.
Publicado: (2021)

Human RELA dominant-negative mutations underlie type I interferonopathy with autoinflammation and autoimmunity
por: Moriya, Kunihiko, et al.
Publicado: (2023)

Use of lung ultrasound in school-aged children with wheezing
por: Attanasi, Marina, et al.
Publicado: (2023)

Effect of Invasive Mechanical Ventilation at Birth on Lung Function Later in Childhood
por: Di Filippo, Paola, et al.
Publicado: (2022)

Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy
por: Meesilpavikkai, Kornvalee, et al.
Publicado: (2019)

Fine-tuning of type I IFN-signaling in microglia — implications for homeostasis, CNS autoimmunity and interferonopathies
por: Goldmann, Tobias, et al.
Publicado: (2016)

Type I Interferonopathy due to a Homozygous Loss-of-Inhibitory Function Mutation in STAT2
por: Zhu, Gaofeng, et al.
Publicado: (2023)

The Role of Breastfeeding on Respiratory Outcomes Later in Childhood
por: Di Filippo, Paola, et al.
Publicado: (2022)

Monogenic interferonopathy presenting as CMV infection in infancy
por: Schütz, C, et al.
Publicado: (2015)

Identification of type I interferonopathies using blood interferon signature: the experience of a pediatric rheumatology center
por: Volpi, S, et al.
Publicado: (2015)

Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS)
por: Kanazawa, Nobuo, et al.
Publicado: (2023)

Effect of tonsillectomy in a child with obesity and obstructive sleep apnea: A case report and review of the literature
por: Di Filippo, Paola, et al.
Publicado: (2023)

The Role of Serum Calprotectin in Defining Disease Outcomes in Non-Systemic Juvenile Idiopathic Arthritis: A Pilot Study
por: d’Angelo, Debora Mariarita, et al.
Publicado: (2023)

Type I interferonopathies with novel compound heterozygous TREX1 mutations in two siblings with different symptoms responded to tofacitinib
por: Zhang, Shiyu, et al.
Publicado: (2021)

Human Disease Phenotypes Associated with Loss and Gain of Function Mutations in STAT2: Viral Susceptibility and Type I Interferonopathy
por: Duncan, Christopher James Arthur, et al.
Publicado: (2021)

Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy
por: Gruber, Conor, et al.
Publicado: (2020)

Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series From a Single Center in China
por: Li, Wendao, et al.
Publicado: (2022)

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
por: Sanchez, Gina A. Montealegre, et al.
Publicado: (2018)

Evaluation of Bone Age in Children: A Mini-Review
por: Cavallo, Federica, et al.
Publicado: (2021)

Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition
por: Galbraith, Matthew D., et al.
Publicado: (2023)

Overview of Plasma and Platelet Transfusions in Critically Ill Children
por: Kahn, Stacie, et al.
Publicado: (2020)

Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome
por: Meuwissen, Marije E.C., et al.
Publicado: (2016)

ZBP1 contributes to interferonopathies caused by impaired ADAR1 function
por: Fang, Xiuwu, et al.
Publicado: (2022)

An Overview of Vascular Dysfunction and Determinants: The Case of Children of African Ancestry
por: Matjuda, Edna N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_61v099gf5m2ppgcu8l6r6eag51